Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients

Biochimie

Volumn 92, Issue 9, 2010, Pages 1207-1212

  Grover, Sandeep ^a   Bala, Kiran ^b   Sharma, Sangeeta ^b   Gourie Devi, M ^b   Baghel, Ruchi ^a   Kaur, Harpreet ^a   Gupta, Meenal ^a   Talwar, Puneet ^a   Kukreti, Ritushree ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

ABCB1; Antiepileptic drugs; Drug response; Epilepsy; Pharmacogenomics

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; MULTIDRUG RESISTANCE PROTEIN 1; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA EXTRACTION; DRUG RESPONSE; EPILEPSY; EVALUATION AND FOLLOW UP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PATIENT; PHARMACOGENOMICS; RECURRENT DISEASE; STEADY STATE;

EID: 77955847469     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.04.008     Document Type: Article

References (41)

1. Luna-Tortos C., Fedrowitz M., Loscher W. Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology 2008, 55:1364-1375.
2. Potschka H., Fedrowitz M., Loscher W. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 2001, 12:3557-3560.
3. Aronica E., Gorter J.A., Ramkema M., et al. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 2004, 45:441-451.
4. Tishler D.M., Weinberg K.I., Hinton D.R., Barbaro N., Annett G.M., Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995, 36:1-6.
5. Leschziner G.D., Andrew T., Pirmohamed M., Johnson M.R. ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J. 2007, 7:154-179.
6. Siddiqui A., Kerb R., Weale M.E., et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med. 2003, 348:1442-1448.
7. Zimprich F., Sunder-Plassmann R., Stogmann E., Gleiss A., et al. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 2004, 63:1087-1089.
8. Tan N.C., Heron S.E., Scheffer I.E., et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 2004, 63:1090-1092.
9. Sills G.J., Mohanraj R., Butler E., et al. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 2005, 46:643-647.
10. Kwan P., Baum L., Wong V., et al. Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav. 2007, 11:112-117.
11. Hung C.C., Jen T.J., Kao P.J., Lin M.S., Liou H.H. Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses. Pharmacogenomics 2007, 8:1151-1158.
12. Seo T., Ishitsu T., Ueda N., et al. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 2006, 7:551-561.
13. Ferraro T.N., Buono R.J. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview. Epilepsy Behav. 2005, 7:18-36.
14. Szoeke C., Sills G.J., Kwan P., et al. Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from International Pharmacogenetic Cohorts. Epilepsia 2009, 50:1689-1696.
15. Tan N.C., Mulley J.C., Berkovic S.F. Genetic association studies in epilepsy: " the truth is out there" Epilepsia 2004, 45:1429-1442.
16. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
17. S. Grover, M. Gourie-Devi, R. Baghel, et al., Pharmacogenomics of epilepsy: genetic profile of patients with epilepsy from North India, on first line antiepileptic drugs and potential directions for personalized treatment, Pharmacogenomics, in press.
18. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
19. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
20. Stephens M., Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 2003, 73:1162-1169.
21. Lakhan R., Misra U.K., Kalita J., et al. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Epilepsy Behav. 2009, 14:78-82.
22. Dombrowski S.M., Desai S.Y., Marroni M., et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 2001, 42:1501-1506.
23. Si sodiya S.M., Lin W.R., Squier M.V., Thom M. Multidrug resistance protein 1 in focal cortical dysplasia. Lancet 2001, 357:42-43.
24. Hoffmeyer S., Burk O., von Richter O., et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. 2000, 97:3473-3478.
25. Vogelgesang S., Kunert-Keil C., Cascorbi I., et al. Expression of multidrug transporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy. Clin. Neuropathol. 2004, 23:223-231.
26. Basic S., Hajnsek S., Bozina N., et al. The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across blood-brain barrier in patients with generalized epilepsy. Seizure 2008, 17:524-530.
27. Mosyagin I., Runge U., Schroeder H.W., et al. Association of ABCB1 genetic variants 3435C > T and 2677G > T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients. Epilepsia 2008, 49:1555-1561.
28. Kerb R., Aynacioglu A.S., Brockmoller J., et al. The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. Pharmacogenomics J. 2001, 1:204-210.
29. Ebid A.H., Ahmed M.M., Mohammed S.A. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ther. Drug Monit. 2007, 29:305-312.
30. Simon C., Stieger B., Kullak-Ublick G.A., et al. Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition. Acta. Neurol. Scand. 2007, 115:232-242.
31. Hung C.C., Tai J.J., Lin C.J., Lee M.J., Liou H.H. Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 2005, 6:411-417.
32. Kwan P., Wong V., Ng P.W., et al. Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese. Pharmacogenomics 2009, 10:723-732.
33. Ozgon G.O., Bebek N., Gul G., Cine N. Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. Eur. Neurol. 2008, 59:67-70.
34. Chen L., Liu C.Q., Hu Y., Xiao Z.T., Chen Y., Liao J.X. Association of a polymorphism in MDR1 C3435T with response to antiepileptic drug treatment in ethic Han Chinese children with epilepsy. Zhongguo Dang Dai Er Ke Za Zhi 2007, 9:11-14.
35. Kim D.W., Kim M., Lee S.K., Kang R., Lee S.Y. Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure 2006, 15:344-347.
36. Dericioglu N., Babaoglu M.O., Yasar U., Bal I.B., Bozkurt A., Saygi S. Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene. Epilepsy Res. 2008, 80:42-46.
37. Kim D.W., Lee S.K., Chu K., et al. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy. Epilepsy Res. 2009, 84:86-90.
38. Shahwan A., Murphy K., Doherty C., et al. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res. 2007, 73:192-198.
39. Petrovski S., Szoeke C.E., Sheffield L.J., et al. Multi-SNP pharmacogenomic classifier is superior to single-SNP in complex diseases. Pharmacogenet. Genomics 2009, 19:147-152.
40. Vahab S.A., Sen S., Ravindran N., et al. Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population. Drug Metab. Pharmacokinet. 2009, 24:255-260.
41. Luna-Tortós C., Fedrowitz M., Löscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology 2010, 58:1019-1032.